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OBJECTIVE: To evaluate the results of surgical treatment of renal cell carcinoma (RCC) with inferior
vena cava (IVC) thrombus and describe the use of a transabdominal approach with liver mobilization to
avoid cardiopulmonary bypass (CPB).
METHODS: From February 2002 to January 2006, 109 patients with RCC were surgically treated at
Siriraj Hospital. Twelve patients had an IVC thrombus, infrahepatic (level I), retrohepatic (level II), supra-
hepatic (level III) and intra-atrial (level IV) in one, two, eight and one patient, respectively. Patients’ char-
acteristics, pathological features, survival and morbidity were evaluated.
RESULTS: Mean age was 58 years (range, 37–74 years). CPB was used in one patient with level IV thrombus.
All patients (92%) with level I–III IVC thrombi underwent successful removal by transabdominal approach
without any form of bypass. Mean operative time was 302 minutes (range, 195–420 minutes). The mortal-
ity rate was 16% (2 of 12) with sepsis and pulmonary embolism. One patient had colonic injury requiring
primary repair. At the mean follow-up of 17 months (range, 3–35 months), of 10 patients, one died due
to distant metastases, two were lost to follow-up and seven (60%) were still alive. Five patients (42%) were
disease-free at the last follow-up.
CONCLUSION: These results support the aggressive surgical removal of RCC with IVC thrombus as the
initial treatment. Most of the thrombi can be approached and safely controlled by a transabdominal
approach without any form of bypass. Tumour thrombus removal provides a high survival chance and
offers improvement in quality of life. [Asian J Surg 2008;31(2):75–82]
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Introduction
A tumour thrombus in the inferior vena cava (IVC) occurs
in 4–10% of patients with renal cell carcinoma (RCC).1,2
Radical surgical removal of RCC with IVC thrombus is
the standard method of treatment because it offers a sig-
nificant survival benefit. However, surgical removal of an
IVC thrombus still has a significant rate of major periop-
erative morbidity and mortality (2.7–13%).3,4 In the last
three decades, there have been improvements in surgical
techniques and perioperative care that decreased morbidity
and mortality. The level of tumour extension in the IVC 
is an important determinant when planning the surgical
approach. Usually, infrahepatic tumour extension can be
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safely removed by simple proximal and distal control of
the IVC. It is widely agreed that cardiopulmonary bypass
(CPB) with or without circulatory arrest is essential for
removal of a thrombus that extends into the right
atrium.5,6 However, there is controversy in the management
of a tumour thrombus that extends to the retrohepatic or
supradiaphragmatic IVC without entering the right
atrium, although some previous studies advocated the use
of CPB or the use of venovenous bypass to remove the
tumour thrombus. However, complications due to these
approaches, such as coagulopathy or central nervous sys-
tem complications, have been reported.7 Furthermore,
recent studies have suggested that the removal of a retro-
hepatic tumour thrombus can be done without any form
of bypass with minimal morbidity and low mortality.8–11
To our knowledge, little data on this kind of surgery have
been published in Southeast Asia. We report our surgical
experience in the treatment of patients with RCC who had
an IVC thrombus at our hospital. We describe and evalu-
ate the feasibility of a transabdominal approach for
tumour thrombus removal, without any form of CPB, at
IVC level II–III using a liver mobilization technique.
Patients and methods
From February 2002 to January 2006, 109 patients with
RCC were surgically treated at the division of Urology,
Siriraj Hospital, Mahidol University, Bangkok. Of these
patients, 12 (11%) had IVC involvement and underwent
radical nephrectomy with removal of the tumour thrombus.
The primary RCC of the kidney and thrombus level was
initially evaluated with computed tomography (CT).
Magnetic resonance imaging (MRI) or echocardiography
was used in selected patients. The cranial extent of the
tumour thrombus was classified by Neves and Zinke.12
Of the 12 patients, one had a level I thrombus (< 2 cm
above the renal vein in the IVC), two had a level II throm-
bus (retrohepatic and below the hepatic veins), eight had
a level III thrombus (extending above the hepatic veins),
including two patients with supradiaphragmatic involve-
ment, and another patient had a level IV thrombus (in 
the right atrium). No preoperative embolization of the
renal artery was performed in any patient. For the level I
tumour, the operation was performed with simple vascular
control. CPB and deep hypothermic circulatory arrest
(DHCA) were used in the patient with the level IV tumour.
All the other patients with level II and III thrombi were
treated by a transabdominal approach without a bypass
procedure.
Surgical technique
For a level II or III thrombus, the surgical approach used
a modified Chevron incision. This incision could be ex-
tended in the midline vertically to the xiphoid process if
necessary. The kidney was mobilized posteriorly and the
renal artery was ligated to prevent severe haemorrhage
during dissection. Then, the liver was mobilized and
could be rotated to the midline, exposing the retrohepatic
IVC (Figure 1). The only remaining structural attach-
ments were the hepatic veins and the porta hepatis (“pig-
gyback” liver mobilization) as described previously.11,13
Natural collateral venous channels, such as the ascending
lumbar veins and the azygos or hemiazygos system,
should not be ligated during dissection of the IVC. This
preservation was important for providing a natural
bypass and preventing a decreased venous return during
cross-clamping of the IVC. Vascular isolation of the IVC
was then achieved superior and inferior to the thrombus.
The major hepatic veins were then in direct view and the
surgeon could manipulate by the Pringle manoeuvre. If
possible, we initially attempted to use the technique of
milking the thrombus down the IVC, below the level of
the major hepatic vein and applying a vascular clamp
below them. This technique allowed continuous hepatic
venous drainage during closure of the IVC. In the situa-
tion that the thrombus could not be milked due to adher-
ence with the vena caval wall, cavotomy above the hepatic
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Figure 1. Intraoperative photograph shows full mobilization of
the right lobe of the liver allowing exposure of the retrohepatic
inferior vena cava (IVC) and its thrombus.
vein was performed. For a supradiaphragmatic thrombus,
a few adjuncts were useful. Intraoperative transoesophageal
echocardiography was used in delineating the cranial extent
of the thrombus. The diaphragm was cut in the midline
at the hiatus, the pericardium opened and the supradi-
aphragmatic IVC was encircled. The IVC was opened
along its anterolateral surface. The thrombus was care-
fully and gently removed (Figure 2). After the thrombus was
removed, suture closure began proximally.
Patients were followed-up at 3–6-month intervals post-
operatively. To evaluate the use of the transabdominal
approach and tumour thrombus removal without any
forms of bypass as in the technique described above, inpa-
tient and outpatient record forms were reviewed retro-
spectively. Survival was calculated to the last follow-up
visit for surviving patients or death. Patients’ characteristics,
pathological features, survival, morbidity and mortality
were evaluated.
Results
Of 12 patients, 10 were male and two were female. Mean
age was 58 years (range, 37–74 years). Nine patients had
RCC on the right kidney and three were on the left. The
presenting symptoms were gross haematuria in six (50%)
patients, abdominal mass in three (25%), oedema of the
lower extremities in one (8%), weight loss in one (8%) and
no symptoms in one (8%). One patient had lung metasta-
sis and another had liver metastasis at the time of diagno-
sis. One patient had recurrent RCC within the IVC after
radical nephrectomy. In four (33%) cases, the upper level
of the thrombus could not be visualized with CT, there-
fore MRI and echocardiography were used.
Only one (8%) patient with a level IV tumour throm-
bus that was adherent to the atrial wall needed CPB. All
the rest had tumour thrombi at levels I, II and III (92%) that
were successfully removed by the transabdominal approach.
For patients with tumour thrombi at level II or III, the liver
was mobilized and preserved with natural venovenous
bypass. This technique allowed complete vascular exclusion
of the IVC without any form of bypass. Six of eight
patients (75%) with a tumour thrombus at level III were
successfully treated by a technique of milking the tumour
back below the hepatic veins. Another two patients needed
a suprahepatic IVC cross clamp because the thrombus
could not be milked due to adherence with the vena caval
wall. There was no intraoperative mortality. The mean
operative time was 302 minutes (range, 195–420 minutes).
Mean blood loss was 4,150 mL (range, 1,200–8,000 mL)
and mean blood transfusion was 7.8 units (range, 2–17
units). No tumour or gas emboli were detected by using
continuous intraoperative transoesophageal echocardio-
graphy. A complication occurred in one (8%) patient who
had intraoperative colonic injury requiring immediate
primary repair. No patient required re-operation from
bleeding or other complications. No patient had immediate
renal or hepatic insufficiency after the operation. There
were two early postoperative deaths (16%). One patient
with a level IV thrombus died of sepsis 6 weeks after sur-
gery. Another patient died on the 20th postoperative day
from pulmonary embolism.
The mean size of the renal mass was 14 cm in diameter
(range, 6–20 cm). Pathological examination showed clear
cell type and papillary type in nine and three patients respec-
tively. Seven patients had extracapsular invasion. Three
patients had regional node metastases. The multiple liver
metastases in one patient were pathologically confirmed.
At the mean follow-up of 17 months (range, 3–35
months), one patient with liver metastasis at the time of
operation died of tumour progression despite adjuvant
immunotherapy with interferon, two patients were lost to
follow-up and seven (60%) were alive. Of the seven patients
who were alive, one patient had a recurrent tumour with
bone metastasis, and one patient with preoperative mul-
tiple small pulmonary nodules underwent immunotherapy
with interferon and was still alive with unchanged pul-
monary nodules at the last follow-up at 29 months.
Another five patients, more specifically one patient with
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Kidney
Thrombus
Figure 2. Specimen of the completely removed inferior vena cava
thrombus.
level I, one with level II, and three patients with level III
thrombi, had good performance status and were disease-free
at the last follow-up. During follow-up, MRI or Doppler
ultrasound imaging demonstrated an adequate iliac and
vena caval flow in all cases. Perioperative data are presented
in Table 1.
Discussion
Vena caval tumour thrombus extension in RCC is rela-
tively uncommon, occurring in 4–10% of cases.1,2 In our
series, the incidence of IVC tumour thrombus was 11%
and the rate of tumour thrombus above level II was 92%
(9/12). This is a high rate of patients diagnosed with a
high tumour thrombus level, considering the referral sys-
tem to our centre. CT scanning of the abdomen was rou-
tinely used for staging RCC in this study. In four of 12
patients (33%) with level II or IV thrombi, MRI and echocar-
diography were needed for better evaluation of the upper
extension. The above investigations facilitated preoperative
surgical planning and responsible evaluation in our series.
Berg first reported nephrectomy and cavotomy in
treating RCC with thrombus extending into the IVC.14
Most reports over the last decade have documented the
clear superiority of surgery over other alternative treat-
ments.15–18 The surgical technique depends on the cranial
extent of the vena cava thrombus. An infrahepatic throm-
bus (level I) can be safely removed completely via abdominal
isolation of the IVC. In one patient with a level I throm-
bus in our series, the tumour and thrombus were success-
fully and safely removed by the above technique. On the
other hand, a thrombus extending to the right atrium (level
IV) requires mandatory large thoracoabdominal access with
CPB, which has been reported in many series.5,6 In our
series, we successfully treated a level IV thrombus with the
above strategy. Although CPB is useful in patients with a
thrombus at level IV, it may increase the mortality as pre-
viously reported.16,19 One of our patients with a thrombus
at level IV who underwent CPB died of sepsis and multiple
organ failure.
Controversy exists in the management of a tumour
thrombus extending to the retrohepatic and suprahepatic
IVC (levels II and III) because exposure and isolation of
the IVC is in a complex anatomical region. Several tech-
niques have been developed to prevent major bleeding,
embolism from the tumour thrombus and hepatic or
renal dysfunction during dissection. Several authors20,21
have recommended CPB with or without DHCA as a
means of ensuring stable haemodynamic status during
clamping of the IVC and provision of a bloodless field for
tumour removal in these patients. However, CPB and
DHCA are time-consuming techniques with complica-
tions.7 A thoracoabdominal approach can be managed
without any form of bypass but with the need for vascular
control over the intrapericardial IVC. Langenburg et al22
and Skinner et al4 reported this technique with a mortality
of 8–13%. Recently, many reports have described a trans-
abdominal approach to levels II and III tumour thrombi
that decrease morbidity and mortality related to CPB and
DHCA or venovenous bypass.8–11 We report our experience
with resection of IVC tumour thrombi at levels II and III
with a full abdominal surgical technique. Our approach
using a technique of extensive liver mobilization to facili-
tate retrohepatic IVC exposure allows resection of the
thrombus with limited risk of massive haemorrhage and
respiratory complications, which are the major hazards in
this type of surgery. In our series, all 10 patients with a
level II or III thrombus were successfully treated with this
technique. Table 28,10,11,15–17,21,23,24 shows an overview of
IVC thrombus management in many series, including ours.
To the previous studies,25,26 we add our experience in two
cases with removal of the IVC thrombus without CPB,
even in the presence of thoracic extension. As acknowl-
edged, this approach is not always feasible, for example
when the thrombus is adherent to the venous wall and
when there is difficulty in achieving vascular control in
the thoracic region. However, with a well-planned surgi-
cal approach, we believe that this technique is safe and
effective in selected cases to avoid the potential added risk
of morbidity from CPB and DHCA.
Using the technique of milking the tumour down to
the hepatic vein and proximal vascular control below the
hepatic vein during cavotomy repair, the interruption to
the hepatic and renal circulation was less than 30 minutes
in our series. This is acceptable when compared with the
reported tolerable normothermic continuous hepatic
ischaemic time of 15–30 minutes.7 Hence, none of our
patients had significant postoperative hepatic and renal
dysfunction. This step is obviously not feasible and safe
when the IVC wall is infiltrated by the thrombus. This still
remains a good method to control the proximal throm-
bus above the hepatic vein to reduce the risk of thrombus
fragmentation. In our series, tumour thrombus could be
easily removed from the IVC wall and the venous wall was
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directly inspected to confirm the absence of residual
tumour. In some patients, if there was tumour infiltration
of the venous wall, IVC wall resection was performed 
to accomplish complete tumour removal. In Tsuji et al’s
series,20 venous reconstructions were done in all patients
to prevent venous insufficiency. In our series, no IVC
reconstructions were performed because the narrowing of
the vena cava was allowed adequate venous return and no
postoperative complications occurred.
In some cases, more aggressive fluid replacement was
needed to obtain haemodynamic stability during supra-
hepatic IVC cross-clamping without venovenous bypass.
The technique of partial or total abdominal aortic cross
clamping might be an effective procedure to maintain sys-
temic blood pressure. However, this procedure was not
necessary in our series.
The mean intraoperative transfusion was 7.8 units,
which was higher than in previous reports (2.2–11.25
units)10,23 because of occasional massive bleeding that oc-
curred during large tumour nephrectomy (mean tumour
size, 14 cm) and because of the high tumour thrombus level
in our series. The blood loss in this case was the aberrant
systemic venous drainage resulting from the vena caval
obstruction. Many reports recommend preoperative renal
arterial embolization to reduce potential blood loss.18,27
Because arterial embolization remains controversial with
complications, it was not used in our series. Occasionally, in
the earlier cases, we experienced bleeding from non-occluded
lumbar and hepatic veins during cavotomy repair. We believe
that the blood loss will be further reduced as our surgical
expertise increases.
There was no intraoperative mortality in our study
except for only one complicated by colonic injury in a
patient who had previous intra-abdominal surgery. How-
ever, there was 16% postoperative mortality, which is high
when compared to other series (2.7–13%).3,4 Major causes of
death in most series were pulmonary embolism, myocardial
infarction and complications related to the bypass proce-
dures. The causes of death in our series were sepsis and pul-
monary embolism. The first patient with atrial thrombus
had respiratory sepsis and developed multiorgan failure.
Another patient had deep iliac vein thrombus postopera-
tively and was treated by heparinization. Unfortunately, this
patient died of sudden cardiac arrest and autopsy showed
pulmonary embolism. Wellons et al28 suggested that the
placement of a temporary suprarenal IVC filter at the time
of surgery can reduce the incidence of pulmonary embolism
postoperatively. However, hypercoagulable cancer patients
are at an increased risk of developing recurrent thrombosis
around the IVC filter; thus, we did not use a prophylactic
IVC filter in our series.
After a mean follow-up of 14 months, seven patients
were still alive and five of these patients were disease-free at
the time of the last follow-up. It was also noted that no
intracaval tumour recurrence was found in any patient.
Our results confirmed that complete thrombus removal can
reduce the spread of tumour cells and intracaval tumour
recurrence.
While the oncological prognostic value of this series is
obviously limited by the small patient numbers, our over-
all results were expected: (i) the presence of perinephric
fat invasion and regional node involvement were associ-
ated with disease progression; (ii) a very small percentage
(1/12) of our patients died of postoperative complications.
Due to the rapid progress of metastatic disease, the qual-
ity of the rest of life has to be considered. Bastian et al23
reported a significant difference in cancer specific survival
between patients presenting with and without metastatic
disease at the time of surgery. However, Sweeney et al16
demonstrated no significant difference in 5-year survival
between patients with and without metastases and differ-
ent performance status at presentation. In our series, two
patients with metastases at the time of surgery had differ-
ent survival. One patient with extensive liver metastases
and poor performance status died 2 months after surgery,
whereas the other patient with small multiple pulmonary
nodules with good performance status was still alive with
stable disease at 29 months postoperatively. The survival
benefit of tumour thrombus surgery is likely to reflect
patient selection; in other words, the general condition of
the patient at presentation represents a well known key
factor. The patient who died 2 months after surgery in our
series offers a good example. Several studies have shown
5- and 10-year survival rates between 30–72%29,30 and
29%,17 respectively. Because of the small number of patients,
statistical analysis of survival in our series was limited.
All patients with RCC and IVC tumour thrombus
should be considered for operation. These tumours can
be completely removed by an aggressive approach. In our
series, CPB was used only in cases involving an intra-atrial
thrombus. Surgical removal of these cancers through a
transabdominal approach with liver mobilization tech-
nique, even in retrohepatic IVC, is possible and avoids the
potential added risk of morbidity of CPB. We believe that
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complete surgical excision of the tumour and its thrombus
provides a high chance of survival and offers improvement
in quality of life.
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